6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Nuclear medicine imaging of inflammatory/infective disorders of the abdomen.

      Nuclear Medicine Communications
      Abdomen, radionuclide imaging, Appendicitis, epidemiology, Blood Vessel Prosthesis, Clinical Trials as Topic, Comorbidity, Humans, Inflammatory Bowel Diseases, Nuclear Medicine, methods, statistics & numerical data, Practice Guidelines as Topic, Prosthesis-Related Infections, Radioisotopes, diagnostic use, Radionuclide Imaging, Vasculitis

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Different nuclear medicine modalities are currently used to study inflammatory and infective disorders of the abdomen. They are usually complementary to radiology and endoscopy, but they play a pivotal role in particular clinical situations. Several radiopharmaceuticals (e.g., 111In or 99mTc labelled white blood cells, monoclonal antibodies, human polyclonal immunoglobulins, 75Ga citrate) are commercially available, but they can not be used indifferently to study abdominal inflammatory disorders. The lack of comparative studies showing the accuracy of each radiopharmaceutical for the study of inflammatory/infective abdominal diseases does not allow the best nuclear medicine technique(s) to be chosen in an evidence-based manner. To this end we performed a meta-analysis of peer reviewed articles published between 1984 and 2004 describing the use of nuclear medicine imaging for the study of inflammatory bowel disorders, appendicitis and vascular graft infections. A guideline for the optimal radiopharmaceutical(s) to be used in each clinical condition and for different aims is provided.

          Related collections

          Author and article information

          Comments

          Comment on this article